img

Global Perennial Allergic Rhinitis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Perennial Allergic Rhinitis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Perennial Allergic Rhinitis Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Perennial Allergic Rhinitis Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Perennial Allergic Rhinitis Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Perennial Allergic Rhinitis Drug key manufacturers include Faes Farma, S.A., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co., Inc., Merck & Co., Inc., Pfizer Inc., Shionogi & Co., Ltd. and VentiRx Pharmaceuticals, Inc., etc. Faes Farma, S.A., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co., Inc. are top 3 players and held % sales share in total in 2022.
Perennial Allergic Rhinitis Drug can be divided into APC-3000, Asapiprant, Bilastine and Desloratadine, etc. APC-3000 is the mainstream product in the market, accounting for % sales share globally in 2022.
Perennial Allergic Rhinitis Drug is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Perennial Allergic Rhinitis Drug industry development. In 2022, global % sales of Perennial Allergic Rhinitis Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Perennial Allergic Rhinitis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Faes Farma, S.A.
Glenmark Pharmaceuticals Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Merck & Co., Inc.
Pfizer Inc.
Shionogi & Co., Ltd.
VentiRx Pharmaceuticals, Inc.
Segment by Type
APC-3000
Asapiprant
Bilastine
Desloratadine
Others

Segment by Application


Clinic
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Perennial Allergic Rhinitis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Perennial Allergic Rhinitis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Perennial Allergic Rhinitis Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Perennial Allergic Rhinitis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Perennial Allergic Rhinitis Drug introduction, etc. Perennial Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Perennial Allergic Rhinitis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Perennial Allergic Rhinitis Drug Market Overview
1.1 Perennial Allergic Rhinitis Drug Product Overview
1.2 Perennial Allergic Rhinitis Drug Market Segment by Type
1.2.1 APC-3000
1.2.2 Asapiprant
1.2.3 Bilastine
1.2.4 Desloratadine
1.2.5 Others
1.3 Global Perennial Allergic Rhinitis Drug Market Size by Type
1.3.1 Global Perennial Allergic Rhinitis Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Perennial Allergic Rhinitis Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Perennial Allergic Rhinitis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2018-2024)
2 Global Perennial Allergic Rhinitis Drug Market Competition by Company
2.1 Global Top Players by Perennial Allergic Rhinitis Drug Sales (2018-2024)
2.2 Global Top Players by Perennial Allergic Rhinitis Drug Revenue (2018-2024)
2.3 Global Top Players by Perennial Allergic Rhinitis Drug Price (2018-2024)
2.4 Global Top Manufacturers Perennial Allergic Rhinitis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Perennial Allergic Rhinitis Drug Market Competitive Situation and Trends
2.5.1 Perennial Allergic Rhinitis Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Perennial Allergic Rhinitis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Perennial Allergic Rhinitis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Perennial Allergic Rhinitis Drug Market
2.8 Key Manufacturers Perennial Allergic Rhinitis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Perennial Allergic Rhinitis Drug Status and Outlook by Region
3.1 Global Perennial Allergic Rhinitis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Perennial Allergic Rhinitis Drug Historic Market Size by Region
3.2.1 Global Perennial Allergic Rhinitis Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Perennial Allergic Rhinitis Drug Sales in Value by Region (2018-2024)
3.2.3 Global Perennial Allergic Rhinitis Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Perennial Allergic Rhinitis Drug Forecasted Market Size by Region
3.3.1 Global Perennial Allergic Rhinitis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Perennial Allergic Rhinitis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Perennial Allergic Rhinitis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Perennial Allergic Rhinitis Drug by Application
4.1 Perennial Allergic Rhinitis Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Perennial Allergic Rhinitis Drug Market Size by Application
4.2.1 Global Perennial Allergic Rhinitis Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Perennial Allergic Rhinitis Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Perennial Allergic Rhinitis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2018-2024)
5 North America Perennial Allergic Rhinitis Drug by Country
5.1 North America Perennial Allergic Rhinitis Drug Historic Market Size by Country
5.1.1 North America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Perennial Allergic Rhinitis Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Perennial Allergic Rhinitis Drug Sales in Value by Country (2018-2024)
5.2 North America Perennial Allergic Rhinitis Drug Forecasted Market Size by Country
5.2.1 North America Perennial Allergic Rhinitis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Perennial Allergic Rhinitis Drug Sales in Value by Country (2024-2034)
6 Europe Perennial Allergic Rhinitis Drug by Country
6.1 Europe Perennial Allergic Rhinitis Drug Historic Market Size by Country
6.1.1 Europe Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Perennial Allergic Rhinitis Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Perennial Allergic Rhinitis Drug Sales in Value by Country (2018-2024)
6.2 Europe Perennial Allergic Rhinitis Drug Forecasted Market Size by Country
6.2.1 Europe Perennial Allergic Rhinitis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Perennial Allergic Rhinitis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Perennial Allergic Rhinitis Drug by Region
7.1 Asia-Pacific Perennial Allergic Rhinitis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Perennial Allergic Rhinitis Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Perennial Allergic Rhinitis Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Perennial Allergic Rhinitis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Perennial Allergic Rhinitis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Perennial Allergic Rhinitis Drug Sales in Value by Region (2024-2034)
8 Latin America Perennial Allergic Rhinitis Drug by Country
8.1 Latin America Perennial Allergic Rhinitis Drug Historic Market Size by Country
8.1.1 Latin America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Perennial Allergic Rhinitis Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Perennial Allergic Rhinitis Drug Sales in Value by Country (2018-2024)
8.2 Latin America Perennial Allergic Rhinitis Drug Forecasted Market Size by Country
8.2.1 Latin America Perennial Allergic Rhinitis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Perennial Allergic Rhinitis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Perennial Allergic Rhinitis Drug by Country
9.1 Middle East and Africa Perennial Allergic Rhinitis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Perennial Allergic Rhinitis Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Perennial Allergic Rhinitis Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Perennial Allergic Rhinitis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Perennial Allergic Rhinitis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Perennial Allergic Rhinitis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Faes Farma, S.A.
10.1.1 Faes Farma, S.A. Company Information
10.1.2 Faes Farma, S.A. Introduction and Business Overview
10.1.3 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Products Offered
10.1.5 Faes Farma, S.A. Recent Development
10.2 Glenmark Pharmaceuticals Ltd.
10.2.1 Glenmark Pharmaceuticals Ltd. Company Information
10.2.2 Glenmark Pharmaceuticals Ltd. Introduction and Business Overview
10.2.3 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Products Offered
10.2.5 Glenmark Pharmaceuticals Ltd. Recent Development
10.3 Hisamitsu Pharmaceutical Co., Inc.
10.3.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
10.3.2 Hisamitsu Pharmaceutical Co., Inc. Introduction and Business Overview
10.3.3 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Products Offered
10.3.5 Hisamitsu Pharmaceutical Co., Inc. Recent Development
10.4 Merck & Co., Inc.
10.4.1 Merck & Co., Inc. Company Information
10.4.2 Merck & Co., Inc. Introduction and Business Overview
10.4.3 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Products Offered
10.4.5 Merck & Co., Inc. Recent Development
10.5 Pfizer Inc.
10.5.1 Pfizer Inc. Company Information
10.5.2 Pfizer Inc. Introduction and Business Overview
10.5.3 Pfizer Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Inc. Perennial Allergic Rhinitis Drug Products Offered
10.5.5 Pfizer Inc. Recent Development
10.6 Shionogi & Co., Ltd.
10.6.1 Shionogi & Co., Ltd. Company Information
10.6.2 Shionogi & Co., Ltd. Introduction and Business Overview
10.6.3 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Products Offered
10.6.5 Shionogi & Co., Ltd. Recent Development
10.7 VentiRx Pharmaceuticals, Inc.
10.7.1 VentiRx Pharmaceuticals, Inc. Company Information
10.7.2 VentiRx Pharmaceuticals, Inc. Introduction and Business Overview
10.7.3 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Products Offered
10.7.5 VentiRx Pharmaceuticals, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Perennial Allergic Rhinitis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Perennial Allergic Rhinitis Drug Industrial Chain Analysis
11.4 Perennial Allergic Rhinitis Drug Market Dynamics
11.4.1 Perennial Allergic Rhinitis Drug Industry Trends
11.4.2 Perennial Allergic Rhinitis Drug Market Drivers
11.4.3 Perennial Allergic Rhinitis Drug Market Challenges
11.4.4 Perennial Allergic Rhinitis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Perennial Allergic Rhinitis Drug Distributors
12.3 Perennial Allergic Rhinitis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of APC-3000
Table 2. Major Company of Asapiprant
Table 3. Major Company of Bilastine
Table 4. Major Company of Desloratadine
Table 5. Major Company of Others
Table 6. Global Perennial Allergic Rhinitis Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Perennial Allergic Rhinitis Drug Market Share in Value by Type (2018-2024)
Table 11. Global Perennial Allergic Rhinitis Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Perennial Allergic Rhinitis Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Perennial Allergic Rhinitis Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Perennial Allergic Rhinitis Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Perennial Allergic Rhinitis Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Perennial Allergic Rhinitis Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Perennial Allergic Rhinitis Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Perennial Allergic Rhinitis Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Perennial Allergic Rhinitis Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Perennial Allergic Rhinitis Drug Sales Share by Company (2018-2024)
Table 29. Global Perennial Allergic Rhinitis Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Perennial Allergic Rhinitis Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Perennial Allergic Rhinitis Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Perennial Allergic Rhinitis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Perennial Allergic Rhinitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Perennial Allergic Rhinitis Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Perennial Allergic Rhinitis Drug Market
Table 36. Key Manufacturers Perennial Allergic Rhinitis Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Perennial Allergic Rhinitis Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Perennial Allergic Rhinitis Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Perennial Allergic Rhinitis Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Perennial Allergic Rhinitis Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Perennial Allergic Rhinitis Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Perennial Allergic Rhinitis Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Perennial Allergic Rhinitis Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Perennial Allergic Rhinitis Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Perennial Allergic Rhinitis Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Perennial Allergic Rhinitis Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Faes Farma, S.A. Company Information
Table 111. Faes Farma, S.A. Introduction and Business Overview
Table 112. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Product
Table 114. Faes Farma, S.A. Recent Development
Table 115. Glenmark Pharmaceuticals Ltd. Company Information
Table 116. Glenmark Pharmaceuticals Ltd. Introduction and Business Overview
Table 117. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Product
Table 119. Glenmark Pharmaceuticals Ltd. Recent Development
Table 120. Hisamitsu Pharmaceutical Co., Inc. Company Information
Table 121. Hisamitsu Pharmaceutical Co., Inc. Introduction and Business Overview
Table 122. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Product
Table 124. Hisamitsu Pharmaceutical Co., Inc. Recent Development
Table 125. Merck & Co., Inc. Company Information
Table 126. Merck & Co., Inc. Introduction and Business Overview
Table 127. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Product
Table 129. Merck & Co., Inc. Recent Development
Table 130. Pfizer Inc. Company Information
Table 131. Pfizer Inc. Introduction and Business Overview
Table 132. Pfizer Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Pfizer Inc. Perennial Allergic Rhinitis Drug Product
Table 134. Pfizer Inc. Recent Development
Table 135. Shionogi & Co., Ltd. Company Information
Table 136. Shionogi & Co., Ltd. Introduction and Business Overview
Table 137. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Product
Table 139. Shionogi & Co., Ltd. Recent Development
Table 140. VentiRx Pharmaceuticals, Inc. Company Information
Table 141. VentiRx Pharmaceuticals, Inc. Introduction and Business Overview
Table 142. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Product
Table 144. VentiRx Pharmaceuticals, Inc. Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Perennial Allergic Rhinitis Drug Market Trends
Table 148. Perennial Allergic Rhinitis Drug Market Drivers
Table 149. Perennial Allergic Rhinitis Drug Market Challenges
Table 150. Perennial Allergic Rhinitis Drug Market Restraints
Table 151. Perennial Allergic Rhinitis Drug Distributors List
Table 152. Perennial Allergic Rhinitis Drug Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Perennial Allergic Rhinitis Drug Product Picture
Figure 2. Global Perennial Allergic Rhinitis Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Perennial Allergic Rhinitis Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Perennial Allergic Rhinitis Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of APC-3000
Figure 6. Global APC-3000 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Asapiprant
Figure 8. Global Asapiprant Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Bilastine
Figure 10. Global Bilastine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Desloratadine
Figure 12. Global Desloratadine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Perennial Allergic Rhinitis Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Perennial Allergic Rhinitis Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Perennial Allergic Rhinitis Drug Revenue in 2022
Figure 29. Perennial Allergic Rhinitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Perennial Allergic Rhinitis Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Perennial Allergic Rhinitis Drug Manufacturing Cost Structure
Figure 49. Perennial Allergic Rhinitis Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed